Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24499335 | 0.87 | OGA (0.76) | OGA | |
| SCHEMBL21764666 | 0.79 | OGA (0.67) | OGA | |
| SCHEMBL17551373 | 0.78 | OGA (0.73) | OGA | |
| SCHEMBL21764475 | 0.77 | OGA (0.65) | OGA | |
| SCHEMBL21764423 | 0.77 | OGA (0.71) | OGA | |
| SCHEMBL24499385 | 0.77 | OGA (0.54) | OGA | |
| SCHEMBL25682831 | 0.76 | OGA (0.71) | OGA | |
| SCHEMBL21764665 | 0.76 | OGA (0.84) | OGA | |
| SCHEMBL20760259 | 0.75 | OGA (0.87) | OGA | |
| SCHEMBL25901904 | 0.75 | OGA (0.68) | OGA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220177470-A1 | SULFOXIMINE GLYCOSIDASE INHIBITORS | ASCENEURON SA (CH) | 2022-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220177470-A1 | SULFOXIMINE GLYCOSIDASE INHIBITORS | ENGASE, BACE1, GAA | OGA 57/4885HSD17B10 1024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.